E-LIB Suche - Ergebnisse für: Ackerman, Peter

1

Interprofessional In Situ Simulation to Identify Latent Saf..:

Binder, Cairenn ; Elwell, Diana ; Ackerman, Peter...
Journal of Emergency Nursing. 49 (2023) 1 - p. 50-56 , 2023

Link: https://doi.org/10.1016/..

2

Week 96 Genotypic and Phenotypic Results of the Fostemsavir..:

Gartland, Margaret ; Cahn, Pedro ; DeJesus, Edwin...
Antimicrobial Agents and Chemotherapy. 66 (2022) 6 - p. , 2022

Link: https://doi.org/10.1128/..

3

Pharmacokinetics of Temsavir, the Active Moiety of the HIV-..:

Moore, Katy ; Thakkar, Nilay ; Magee, Mindy...
Antimicrobial Agents and Chemotherapy. 66 (2022) 4 - p. , 2022

Link: https://doi.org/10.1128/..

4

A Phase 1 randomized study of GSK3732394, an investigationa..:

Krystal, Mark ; Chabria, Shiven ; Austin, Daren...
Antiviral Therapy. 27 (2022) 5 - p. 135965352211311 , 2022

Link: https://doi.org/10.1177/..

5

Fostemsavir and ethinyl estradiol drug interaction: Clinica..:

Nwokolo, Nneka ; Post, Elana ; Mageau, A. Savannah...
HIV Medicine. 24 (2022) 5 - p. 580-587 , 2022

Link: https://doi.org/10.1111/..

6

Evaluation of the pharmacokinetic drug-drug interaction bet..:

Wire, Mary Beth ; Magee, Mindy ; Ackerman, Peter..
HIV Research & Clinical Practice. 23 (2022) 1 - p. 1-8 , 2022

Link: https://doi.org/10.1080/..

7

Clinical evidence for a lack of cross-resistance between te..:

Rose, Ronald ; Gartland, Margaret ; Li, Zhufang...
AIDS. 36 (2021) 1 - p. 11-18 , 2021

Link: https://doi.org/10.1097/..

8

ANÁLISE DE SUBGRUPO DOS RESULTADOS DE EFICÁCIA E SEGURANÇA ..:

Ackerman, Peter ; Aberg, Judith ; Molina, Jean‐Michael...
The Brazilian Journal of Infectious Diseases. 25 (2021) - p. 101055 , 2021

Link: https://doi.org/10.1016/..

9

Long-term efficacy and safety of fostemsavir among subgroup..:

Ackerman, Peter ; Thompson, Melanie ; Molina, Jean-Michel...
AIDS. 35 (2021) 7 - p. 1061-1072 , 2021

Link: https://doi.org/10.1097/..

10

Effect of Renal and Hepatic Impairment on the Pharmacokinet..:

Magee, Mindy ; Slater, Jill ; Mannino, Frank...
The Journal of Clinical Pharmacology. 61 (2021) 7 - p. 939-953 , 2021

Link: https://doi.org/10.1002/..

11

Prevalence of gp160 polymorphisms known to be related to de..:

Gartland, Margaret ; Arnoult, Eric ; Foley, Brian T...
Journal of Antimicrobial Chemotherapy. 76 (2021) 11 - p. 2958-2964 , 2021

Link: https://doi.org/10.1093/..

12

834. Characterization of Heavily Treatment Experienced HIV-..:

Chabria, Shiven ; De Wit, Stephane ; Pierce, Amy...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S509-S509 , 2021

Link: https://doi.org/10.1093/..

13

Patient-Reported Outcomes in the Phase III BRIGHTE Trial of..:

Anderson, Sarah-Jane ; Murray, Miranda ; Cella, David...
The Patient - Patient-Centered Outcomes Research. 15 (2021) 1 - p. 131-143 , 2021

Link: https://doi.org/10.1007/..

14

Susceptibility of global HIV-1 clinical isolates to fostems..:

Gartland, Margaret ; Zhou, Nannan ; Stewart, Eugene...
Journal of Antimicrobial Chemotherapy. 76 (2020) 3 - p. 648-652 , 2020

Link: https://doi.org/10.1093/..

15

Effects of Temsavir, Active Moiety of Antiretroviral Agent ..:

Lagishetty, Chakradhar ; Moore, Katy ; Ackerman, Peter..
Clinical and Translational Science. 13 (2020) 4 - p. 769-776 , 2020

Link: https://doi.org/10.1111/..